Neuregulin 1 Fusion–Positive NSCLC
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference30 articles.
1. Scientific advances in lung cancer 2015;Tsao;J Thorac Oncol,2016
2. CD74-NRG1 fusions in lung adenocarcinoma;Fernandez-Cuesta;Cancer Discov,2014
3. Proteolytic processing of neuregulin-1;Willem;Brain Res Bull,2016
4. Molecular pathways: targeting NRG1 fusions in lung cancer;Fernandez-Cuesta;Clin Cancer Res,2015
5. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance;Schram;Nat Rev Clin Oncol,2017
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer;BMC Medicine;2024-02-19
2. Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors;Global Medical Genetics;2024-01
3. Histology and molecular testing;Lung Cancer;2024
4. Rare molecular subtypes of lung cancer;Nature Reviews Clinical Oncology;2023-02-20
5. Construction and prognostic value of enhanced CT image omics model for noninvasive prediction of HRG in bladder cancer based on logistic regression and support vector machine algorithm;Frontiers in Oncology;2023-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3